Delphi Management Partners VIII, L.L.C.
Q3 2021 13F Holdings
- Locationsan mateo, CA
- Num holdings
4
- Value ($000)
$138,461
- Date Filed11/15/2021
- Form type13F-HR
- CIK0001457494
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2021 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
---|---|---|---|---|---|---|---|
TNDM Tandem Diabetes, Inc. | COMMON STOCK | 875372203 | $119.38M | 86 % | 1,000,000 | ||
KPTI Karyopharm Therapeutics, Inc. | COMMON STOCK | 48576U106 | $13.17M | 10 % | 2,263,006 | ||
CALA Calithera Biosciences, Inc. | COMMON STOCK | 13089P101 | $5.29M | 4 % | 2,426,702 | ||
MREO Mereo BioPharma Group PLC | ADS | 589492107 | $621.00K | 0 % | 256,734 |
Rows Per Page
1 - 4 of 410
- 10
- 50
- 100